CELL-FACTORY

Among various large-scale culture solutions, the cell factory has become a widely used platform for efficient and scalable primary cell expansion.

Cell Factory Applications in Gene and Cell Therapy Manufacturing

This article explains the key considerations when scaling up from cell culture flasks to multi-layer cell factories and how this transition supports modern bioprocessing applications.

While medium exchange in small culture vessels is relatively straightforward, the process becomes significantly more complex in a Multilayer Cell Factory. Understanding the challenges and implementing appropriate strategies are essential to maintaining consistency and scalability.

As gene therapy continues to expand from clinical trials to commercial-scale manufacturing, cell factory systems will remain an essential component of efficient, safe, and standardized viral vector production.

In today's rapidly evolving biopharmaceutical landscape, despite the emergence of new technologies like single-use bioreactors, the multilayer cell factory maintains an irreplaceable position in vaccine production. This is especially true during responses to large-scale pandemics (like COVID-19), thanks to its unique and well-established advantages.

As biomanufacturing continues to scale from lab to production, stability, scalability, and traceability have become central to process optimization. The Multilayer Cell Factory System, once viewed merely as a culture vessel, is now evolving into an integrated, intelligent, and closed platform that anchors modern adherent cell culture processes.

This article explores key adjustments and practical solutions in cell culture for vaccine production, focusing on how closed cell factory systems with tubing connections are reshaping the process.

Explore the optimal consumable choices for Vero cell vaccine production, from culture flasks to cell factory, ensuring ISO13485 compliance and high yield.